Ketamine Assisted Psychotherapy for Opioid Use Disorder
Start Date
5/20/2021
Completion Date
5/30/2024
Summary
This pilot clinical trial aims to assess the preliminary efficacy of ketamine as an adjunct for a mindfulness-based intervention for opioid use disorder.
Detailed Description
The purpose of this study is to conduct a Stage 1 randomized controlled trial to test a potential optimization of the evidence-based Mindfulness-Oriented Recovery Enhancement (MORE) intervention for opioid use disorder (OUD). Here we will add Ketamine to MORE (MORE+KAP) and test the MORE+KAP intervention versus the standard MORE intervention in a sample of patients receiving medications for OUD (MOUD; e.g, buprenorphine). The primary aim to is evaluate the extent to which MORE+KAP improves OUD treatment relative to MORE. The secondary aim is to identify the psychobiological mediators of MORE+KAP.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
MORE+KAP
MORE
Conditions
Locations
Center on Mindfulness and Integrative Health Intervention Development
Salt Lake City, Utah 84112
United States